A Comprehensive Review on the Role of MRI in the Assessment of Supratentorial Neoplasms: Comparative Insights Into Adult and Pediatric Cases

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Sep 23

PMID 39310617

Authors

Paritosh N Bhangale

Shivali V Kashikar

Paschyanti R Kasat

Priyal Shrivastava

Anjali Kumari

Affiliations

Soon will be listed here.

Abstract

Magnetic resonance imaging (MRI) is a critical diagnostic tool in assessing supratentorial neoplasms, offering unparalleled detail and specificity in brain imaging. Supratentorial neoplasms in the cerebral hemispheres, basal ganglia, thalamus, and other structures above the tentorium cerebelli present significant diagnostic and therapeutic challenges. These challenges vary notably between adult and pediatric populations due to differences in tumor types, biological behavior, and patient management strategies. This comprehensive review explores the role of MRI in diagnosing, planning treatment, monitoring response, and detecting recurrence in supratentorial neoplasms, providing comparative insights into adult and pediatric cases. The review begins with an overview of the epidemiology and pathophysiology of these tumors in different age groups, followed by a detailed examination of standard and advanced MRI techniques, including diffusion-weighted imaging (DWI), perfusion-weighted imaging (PWI), and magnetic resonance spectroscopy (MRS). We discuss the specific imaging characteristics of various neoplasms and the importance of tailored approaches to optimize diagnostic accuracy and therapeutic efficacy. The review also addresses the technical and interpretative challenges unique to pediatric imaging and the implications for long-term patient outcomes. By highlighting the comparative utility of MRI in adult and pediatric cases, this review aims to enhance the understanding of its pivotal role in managing supratentorial neoplasms. It underscores the necessity of age-specific diagnostic and therapeutic strategies. Emerging MRI technologies and future research directions are also discussed, emphasizing the potential for advancements in personalized imaging approaches and improved patient care across all age groups.

References

Bi W, Hosny A, Schabath M, Giger M, Birkbak N, Mehrtash A . Artificial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin. 2019; 69(2):127-157. PMC: 6403009. DOI: 10.3322/caac.21552. View

Kumar M, Nanga R, Verma G, Wilson N, Brisset J, Nath K . Emerging MR Imaging and Spectroscopic Methods to Study Brain Tumor Metabolism. Front Neurol. 2022; 13:789355. PMC: 8967433. DOI: 10.3389/fneur.2022.789355. View

Hagiwara A, Fujita S, Ohno Y, Aoki S . Variability and Standardization of Quantitative Imaging: Monoparametric to Multiparametric Quantification, Radiomics, and Artificial Intelligence. Invest Radiol. 2020; 55(9):601-616. PMC: 7413678. DOI: 10.1097/RLI.0000000000000666. View

Giedd J, Rapoport J . Structural MRI of pediatric brain development: what have we learned and where are we going?. Neuron. 2010; 67(5):728-34. PMC: 3285464. DOI: 10.1016/j.neuron.2010.08.040. View

Aykan N, Ozatli T . Objective response rate assessment in oncology: Current situation and future expectations. World J Clin Oncol. 2020; 11(2):53-73. PMC: 7046919. DOI: 10.5306/wjco.v11.i2.53. View

Dasgupta A, Gupta T, Jalali R . Indian data on central nervous tumors: A summary of published work. South Asian J Cancer. 2016; 5(3):147-53. PMC: 4991137. DOI: 10.4103/2278-330X.187589. View

Salama G, Heier L, Patel P, Ramakrishna R, Magge R, Tsiouris A . Diffusion Weighted/Tensor Imaging, Functional MRI and Perfusion Weighted Imaging in Glioblastoma-Foundations and Future. Front Neurol. 2018; 8:660. PMC: 5786563. DOI: 10.3389/fneur.2017.00660. View

Cacciotti C, Lenzen A, Self C, Pillay-Smiley N . Recurrence Patterns and Surveillance Imaging in Pediatric Brain Tumor Survivors. J Pediatr Hematol Oncol. 2024; 46(3):e227-e232. PMC: 10956682. DOI: 10.1097/MPH.0000000000002850. View

van Dijken B, Doff A, Enting R, van Laar P, Jeltema H, Dierckx R . Influence of MRI Follow-Up on Treatment Decisions during Standard Concomitant and Adjuvant Chemotherapy in Patients with Glioblastoma: Is Less More?. Cancers (Basel). 2023; 15(20). PMC: 10605145. DOI: 10.3390/cancers15204973. View

10.

Villanueva-Meyer J, Mabray M, Cha S . Current Clinical Brain Tumor Imaging. Neurosurgery. 2017; 81(3):397-415. PMC: 5581219. DOI: 10.1093/neuros/nyx103. View

11.

Aidilla Sahrizan N, Manan H, Hamid H, Abdullah J, Yahya N . Functional Alteration in the Brain Due to Tumour Invasion in Paediatric Patients: A Systematic Review. Cancers (Basel). 2023; 15(7). PMC: 10093754. DOI: 10.3390/cancers15072168. View

12.

Kubicki M, Westin C, Maier S, Mamata H, Frumin M, Ersner-Hershfield H . Diffusion tensor imaging and its application to neuropsychiatric disorders. Harv Rev Psychiatry. 2002; 10(6):324-36. PMC: 2853779. DOI: 10.1080/10673220216231. View

13.

Shaari H, Kevric J, Jukic S, Besic L, Jokic D, Ahmed N . Deep Learning-Based Studies on Pediatric Brain Tumors Imaging: Narrative Review of Techniques and Challenges. Brain Sci. 2021; 11(6). PMC: 8230188. DOI: 10.3390/brainsci11060716. View

14.

Grover V, Tognarelli J, Crossey M, Cox I, Taylor-Robinson S, McPhail M . Magnetic Resonance Imaging: Principles and Techniques: Lessons for Clinicians. J Clin Exp Hepatol. 2015; 5(3):246-55. PMC: 4632105. DOI: 10.1016/j.jceh.2015.08.001. View

15.

Antonelli M, Poliani P . Adult type diffuse gliomas in the new 2021 WHO Classification. Pathologica. 2022; 114(6):397-409. PMC: 9763975. DOI: 10.32074/1591-951X-823. View

16.

Nejat F, El Khashab M, Rutka J . Initial management of childhood brain tumors: neurosurgical considerations. J Child Neurol. 2008; 23(10):1136-48. PMC: 3714852. DOI: 10.1177/0883073808321768. View

17.

Bernstock J, Gary S, Klinger N, Valdes P, Essayed W, Olsen H . Standard clinical approaches and emerging modalities for glioblastoma imaging. Neurooncol Adv. 2022; 4(1):vdac080. PMC: 9268747. DOI: 10.1093/noajnl/vdac080. View

18.

Henriksen O, Alvarez-Torres M, Figueiredo P, Hangel G, Keil V, Nechifor R . High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques. Front Oncol. 2022; 12:810263. PMC: 8961422. DOI: 10.3389/fonc.2022.810263. View

19.

Chandarana H, Wang H, Tijssen R, Das I . Emerging role of MRI in radiation therapy. J Magn Reson Imaging. 2018; 48(6):1468-1478. PMC: 6986460. DOI: 10.1002/jmri.26271. View

20.

Lyndon D, Lansley J, Evanson J, Krishnan A . Dural masses: meningiomas and their mimics. Insights Imaging. 2019; 10(1):11. PMC: 6365311. DOI: 10.1186/s13244-019-0697-7. View